UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Mathematical Modelling Of The Molecular BCR-ABL1 Transcript Response In Chronic Myeloid Leukemia: A Comparison Of Adult and Pediatric Patients

Blood, 2013-11, Vol.122 (21), p.2709-2709

2013

Link zum Volltext

Verfügbarkeit prüfen

Activation of Distinct Inflammatory Pathways in LR-MDS Is Determined By Genetics

Blood, 2022-11, Vol.140 (Supplement 1), p.4011-4012

2022

Link zum Volltext

Verfügbarkeit prüfen

Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.523-525

2022

Link zum Volltext

Verfügbarkeit prüfen

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.13-13

2019

Link zum Volltext

Verfügbarkeit prüfen

Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial

Blood, 2020-11, Vol.136 (Supplement 1), p.1-3

2020

Link zum Volltext

Verfügbarkeit prüfen

The Genes for Tissue Factor F3 and Nuclear Receptor 4A Are Down-Regulated in Early Death Acute Promyelocytic Leukemia Patients

Blood, 2018-11, Vol.132 (Supplement 1), p.3902-3902

2018

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

Blood, 2021-11, Vol.138 (Supplement 1), p.1307-1307

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia

Blood, 2018-11, Vol.132 (Supplement 1), p.1461-1461

2018

Link zum Volltext

Verfügbarkeit prüfen

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Blood, 2017-12, Vol.130 (Suppl_1), p.721-721

2017

Link zum Volltext

Verfügbarkeit prüfen

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Blood, 2017-12, Vol.130, p.2618-2618

2017

Link zum Volltext

Verfügbarkeit prüfen

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Blood, 2016-12, Vol.128 (22), p.2815-2815

2016

Link zum Volltext

Verfügbarkeit prüfen

In-Depth Quantitative Multiplex Proteomics Reveal Subtype-Specific Differences Among Functionally Validated AML Stem Cell Populations

Blood, 2014-12, Vol.124 (21), p.2144-2144

2014

Link zum Volltext

Verfügbarkeit prüfen

Identification Of Novel Markers Of Human AML Stem Cells Using High Resolution Proteomics and Transcriptomics

Blood, 2013-11, Vol.122 (21), p.4194-4194

2013

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine Followed By Intensive Induction/Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML): Results from the Randomized AML-AZA Trial of the Study Alliance Leukemias (SAL)

Blood, 2014-12, Vol.124 (21), p.946-946

2014

Link zum Volltext

Verfügbarkeit prüfen

The Interlaboratory Robustness Of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses Of Hematological Malignancies Performed In 8,867 Cases By An International Network Involving 27 Laboratories

Blood, 2013-11, Vol.122 (21), p.743-743

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Publikationsformmagazinearticle

ThemaBiochemistry & Molecular Biology

ThemaHematology

ThemaMale

ThemaPhysical Sciences

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Mathematical Modelling Of The Molecular BCR-ABL1 Transcript Response In Chronic Myeloid Leukemia: A Comparison Of Adult and Pediatric Patients

Activation of Distinct Inflammatory Pathways in LR-MDS Is Determined By Genetics

Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome

Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial

The Genes for Tissue Factor F3 and Nuclear Receptor 4A Are Down-Regulated in Early Death Acute Promyelocytic Leukemia Patients

EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia

Real World Data on Decitabine Treatment in 296 Patients with Acute Myeloid Leukemia: Outcome and Impact of TP53 Mutations

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Response to Front-Line Imatinib Treatment in Children and Adolescents with CML - Data from a Large Pediatric Cohort

Branched Chain Amino Acid Catabolism Restricts Alpha-Ketoglutarate Levels Resembling IDHmut-Driven DNA Hypermethylation in AML Stem Cells

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Sorafenib Versus Placebo in Addition to Standard Therapy in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia: Results from 267 Patients Treated in the Randomized Placebo-Controlled SAL-Soraml Trial

In-Depth Quantitative Multiplex Proteomics Reveal Subtype-Specific Differences Among Functionally Validated AML Stem Cell Populations

Adverse Prognosis in Acute Myeloid Leukemia with Abnormality Abn(3q): Does EVI1 Matter?

Identification Of Novel Markers Of Human AML Stem Cells Using High Resolution Proteomics and Transcriptomics

Sorafenib Versus Placebo in Addition to Standard Therapy in Adult Patients ≥60 Years with Newly Diagnosed Acute Myeloid Leukemia: Results From the Randomized-Controlled Soraml Trial

Azacitidine Followed By Intensive Induction/Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML): Results from the Randomized AML-AZA Trial of the Study Alliance Leukemias (SAL)

The Interlaboratory Robustness Of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses Of Hematological Malignancies Performed In 8,867 Cases By An International Network Involving 27 Laboratories

The Interlaboratory Robustness of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses of Hematological Malignancies Performed by an International Network Involving 26 Laboratories

A Strong Immune Effect by Allogeneic Stem Cell Transplantation May Improve Survival in AML Patients with a High Ratio of the FLT3-ITD Mutation to the Wt-FLT3 Allele: Results from an Analysis of 257 Patients Treated in the SAL AML-2003 Trial

Aktive Filter

Suchergebnisse filtern